Table 2.
Expert panel evaluation of epidemiologic evidence | Moderate | Low | ||||
---|---|---|---|---|---|---|
Probability of causation | 20%–39% | |||||
Percentile of exposure | 0–9 | 10–24 | 25–49 | 50–74 | 75–89 | >90 |
Percentile assumed | 0 | 10 | 25 | 50 | 75 | 90 |
Urinary total DEHP metabolites, ng/mL | 0 | 9.70 | 16.30 | 29.80 | 53.20 | 93.00 |
Unexposed incidence | 0.0035 | |||||
Incremental incidence | 0 | 0.00121 | 0.00154 | 0.00195 | 0.00238 | 0.00282 |
Attributable cases | 145 000 | |||||
Attributable costs | €1.25 billion |